Search
25/03/2025
Comparative Performances of 4 Serum NfL Assays, pTau181, and GFAP in Patients With Amyotrophic Lateral Sclerosis
Mondesert, E, Delaby, C, de la Cruz, E, Kuhle, J, Benkert, P, Pradeilles, N, Duchiron, M, Morchikh, M, Camu, W, Cristol, JP, Hirtz, C, Esselin, F, Lehmann, S. Comparative Performances of 4 Serum NfL Assays, pTau181, and GFAP in Patients With Amyotrophic Lateral Sclerosis. NEUROLOGY. 2025; 104(6)DOI:10.1212/WNL.0000000000213400. PMID:40009787. IF:8.500(Q1/1D).
25/03/2025
Can ICD Electrograms Help Ventricular Tachycardia Ablation? Results From the Multicenter Randomized AIDEG-VTA Trial
Criado, JLI, Ortiz, M, García-Fernández, J, Martínez-Alday, JD, Font, ER, Moreno, J, López, MA, Almor, JM, Gil, ML, Medina, DG, Granell, RR, Peinado, RP, Gelizo, VB, Muñoz, JJS, Medina, O, Díaz-Parreño, SA, Criado, AI, Gonzalez, JM, Merodio, JMO, Almendral, J. Can ICD Electrograms Help Ventricular Tachycardia Ablation? Results From the Multicenter Randomized AIDEG-VTA Trial. JACC-JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2025; 85(11)DOI:10.1016/j.jacc.2024.10.104. PMID:39772368. IF:22.300(Q1/1D).
25/03/2025
Inositol 1,4,5-Trisphosphate Receptor 1 Gain-of-Function Increases the Risk for Cardiac Arrhythmias in Mice and Humans
Sun, B, Ni, MK, Li, YH, Song, ZP, Wang, H, Zhu, HL, Wei, JH, Belke, D, Cai, ST, Guo, WT, Yao, JJ, Tian, SS, Estillore, JP, Wang, RW, Sondergaard, MT, Brohus, M, Rohde, PD, Mu, YX, Vallmitjana, A, Benitez, R, Hove-Madsen, L, Overgaard, MT, Fishman, GI, Chen, J, Sanatani, S, Wilde, AAM, Fill, M, Ramos-Franco, J, Nyegaard, M, Chen, SRW. Inositol 1,4,5-Trisphosphate Receptor 1 Gain-of-Function Increases the Risk for Cardiac Arrhythmias in Mice and Humans. CIRCULATION. 2025; 151(12)DOI:10.1161/CIRCULATIONAHA.124.070563. PMID:39655431. IF:38.600(Q1/1D).
25/03/2025
Decreased practice effects in cognitively unimpaired amyloid betapositive individuals: a multicenter, longitudinal, cohort study
Tort-Merino, A, Pérez-Millan, A, Falgàs, N, Borrego-ecija, S, Esteller, D, Bosch, B, Castellví, M, Juncà-Parella, J, del Val-Guardiola, A, Fernández-Villullas, G, Antonell, A, Sanchez-Saudinós, MB, Rubio-Guerra, S, Zhu, NL, García-Martínez, M, Pozueta, A, Estanga, A, Ecay-Torres, M, de Luis, CL, Tainta, M, Altuna, M, Rodríguez-Rodríguez, E, Sánchez-Juan, P, Martínez-Lage, P, Lleó, A, Fortea, J, Illán-Gala, I, Balasa, M, Lladó, A, Rami, L, Sánchez-Valle, R. Decreased practice effects in cognitively unimpaired amyloid betapositive individuals: a multicenter, longitudinal, cohort study. ALZHEIMERS & DEMENTIA. 2025; 21(3)DOI:10.1002/alz.70016. PMID:40133248. IF:11.100(Q1/1D).
24/03/2025
Potential of facial biomarkers for Alzheimer's disease and obstructive sleep apnea in Down syndrome and general population
Echeverry-Quiceno, LM, Llambrich, S, Heredia-Lidón, A, Giménez, S, Rozalem-Aranha, M, Inampudi, P, Heuzé, Y, Sevillano, X, Fortea, J, Martinez-Abadias, N, Alzheimers Dis Neuroimaging Initiative. Potential of facial biomarkers for Alzheimer's disease and obstructive sleep apnea in Down syndrome and general population. FASEB JOURNAL. 2025; 39(6)DOI:10.1096/fj.202403009R. PMID:40123509. IF:4.200(Q1/2D).
22/03/2025
SSX and SS18-SSX Antibodies as Additional Tools for Diagnosing Undifferentiated Neoplasms With the EWSR1::SSX3 Fusion
Machado, I, Llombart-Bosch, A, Fumagalli, C, Antonescu, CR. SSX and SS18-SSX Antibodies as Additional Tools for Diagnosing Undifferentiated Neoplasms With the EWSR1::SSX3 Fusion. GENES CHROMOSOMES & CANCER. 2025; 64(3)DOI:10.1002/gcc.70044. PMID:40119747. IF:2.800(Q2/5D).